|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 197.08 USD | -0.77% |
|
+2.15% | -18.15% |
| 17/07 | RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276 | MT |
| 15/07 | Mizuho Adjusts Price Target on ResMed to $220 From $235, Maintains Outperform Rating | MT |
Group ResMed, Inc.: Relations chart
Private companies belonging to the same group as RESMED, INC.
| Company | Manager |
|---|---|
ResMed Pty Ltd.
 ResMed Pty Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Mick Farrell |
ResMed Corp.
 ResMed Corp. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Mick Farrell |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition